Searched for
SHANTHA BIOTECH
- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in HyderabadThe company will continue to reduce its reliance on big products such as Plavix, which is the world’s second-best-selling drug with 2010 sa...06 Oct, 2011, 04.47 AM IST
- Our aim is to bring affordable vaccines to different regions: Harish Iyer, Shantha BiotechBarely two months into his new job after walking away as Biocon’s research head, Iyer echoes the language of a seasoned vaccine maker.16 Aug, 2011, 04.06 AM IST
- Sanofi-Aventis asked to pay 700 cr taxAfter telecom giant Vodafone, it is now the turn of another cross-border merger involving Indian assets to have landed in a tax tangle.13 Nov, 2010, 02.11 PM IST
- Sanofi told to pay Rs 700 cr taxSanofi-Aventis has been asked to cough up a capital gain tax amount of Rs 700 crore by the Income Tax (I-T) department.13 Nov, 2010, 10.49 AM IST
- Other cross-border deals like Vodafone under tax lens: OfficialTax authorities had slapped a showcause notice on Vodafone asking why tax should not be imposed on acquisition of Hutchison stake in Indian...13 Sep, 2010, 01.13 PM IST
- WHO delists Shantha bestsellerShantha Biotech’s bread-winner vaccine has fallen out of favour with the World Health Organisation.03 Aug, 2010, 12.28 AM IST
- Stocks to watch:Reliance Industries, HDIL, Wipro, Videocon Industries, Shantha Biotech, Firstsource SolutionsReliance Industries is considering buying a stake in shale gas assets owned by Pioneer Natural Resources.11 Jun, 2010, 10.04 AM IST
- Sanofi in I-T net, told to pay Rs 650 cr over Shantha buyFrench pharma firm Sanofi Aventis, that acquired India's Shantha Biotech last year, has been asked to pay Rs 650 crore as capital gains tax...11 Jun, 2010, 01.11 AM IST
- Sanofi in I-T net, told to pay Rs 650 cr over Shantha buyFrench pharma firm Sanofi Aventis, that acquired India's Shantha Biotech last year, has been asked to pay Rs 650 crore as capital gains tax...11 Jun, 2010, 01.11 AM IST
- Shantha recalls vaccines worth Rs 72 million on WHO warningShantha Biotech is recalling several lots of its 24 million five-in-one vaccines globally after WHO found it unsuitable for use.29 Apr, 2010, 05.18 AM IST
- Pfizer keen to buy Wockhardt's biotech businessThe American company has just completed the $68-billion acquisition of biotech major Wyeth, which is a new drug developer.29 Oct, 2009, 06.30 AM IST
- Sanofi-Aventis buys Shantha for Rs 3,740 crThe deal between Sanofi its French owners Meriuex Alliance values the unlisted Indian company at Rs 3,740 crore, or about eight times its p...28 Jul, 2009, 02.36 AM IST
- Glaxo, Sanofi-Aventis eye Shantha BiotechIndia’s Shantha Biotech is on the block, with European drugmakers GlaxoSmithKline and Sanofi-Aventis in separate talks to buy out its Franc...30 Mar, 2009, 12.13 AM IST
- Shantha developing $15 cervical cancer vaccineShantha Biotechnics is developing a vaccine against a virus which causes almost all cases of cervical cancer.16 Oct, 2007, 12.01 AM IST
- Biotech generics may get to tap US in shorter timeIn a development that could substantially benefit Indian companies, the US is moving closer to opening up the world’s largest pharmaceutica...02 Jul, 2007, 02.59 AM IST
- Merieux, Shantha to hire 100 scientists for research centreShantha Biotech seems to be abuzz with new activity after French healthcare major Merieux Alliance picked up 60% stake in the company last ...26 Apr, 2007, 02.40 AM IST
- French Merieux picks up 60% in Shantha BiotechIn a cross-border acquisition in the Indian biotech space, the E1.1-bn French major, Merieux Alliance, has snapped up a 60% stake in Hydera...10 Nov, 2006, 01.50 AM IST
Load More- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in Hyderabad
